The presentation covers GLP-1 medications, what they are, how they work, indications, risks and benefits. The implications and considerations of GLP-1 medications for physiotherapists will be covered including considerations for menopause, inflammation, pain conditions, musculokeletal and pelvic health.
Dr Isobelle Smith completed her MBBS at the University of Tasmania in 2014 and gained her FRACP in Endocrinology in 2023.
Her endocrine training was completed at The St Vincent’s Hospital Sydney and The Royal Prince Alfred Hospital. This included sub-specialty training in bone and calcium disorders, obesity medicine and management of anorexia and other eating disorders.
She also has a special interest in osteoporosis, women’s health (PCOS, amenorrhea, menopause transition) thyroid dysfunction and nodules (including antenatal thyroid disease) and athlete health.
Dr Smith is the Endocrine Society of Australia representative for the Centre for Research Excellence in Women’s Health in Reproductive Life (CRE-WHIRL) Clinical Advisory Committee. She has presented at several national conferences and published review articles and original literature on osteoporosis management and barriers to exercise prescription.
Dr Smith is also very involved with amateur and elite sport and has contributed to guidelines and resources on female athlete health including management of recurrent stress fractures and functional hypothalamic amenorrhoea.
Women's, Men's & Pelvic Health National Group
14/4/2026
1.0 hour
Please note: The content of this Lecture on Demand (LOD) was captured via a recording of a live lecture at the APA premises. Due to the nature of the event and the recording method, this LOD may not have captured some of the questions/comments from live audience. Your purchase of this module indicates your acceptance of this.
.png)
